BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 15/07/2024

FDA Launches Interactive Site Tours Program for Cellular and Gene Therapies Regulatory Review

The FDA's CBER is launching an interactive site tours program to enhance review efficiency and quality for regulatory project managers and reviewers, allowing them to tour biotechnology manufacturing facilities and exchange experiences with industry counterparts.

Source: Federal Register — Food and Drug AdministrationOpen original release →